CHF5993 pMDI

CHF5993 · Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF5993 pMDI, covering 2024-09-04 to 2024-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV) [Phase 1]